Medindia LOGIN REGISTER
Medindia

Changes in Opioid Prescribing Practices

by Dr. Jayashree Gopinath on Aug 17 2021 9:47 AM

Changes in initial opioid prescribing practices after the Release of the Centers for Disease Control and Prevention (CDC) Guideline for Prescribing Opioids for Chronic Pain have an effect on opioid use disorder, and overdose rates.

 Changes in Opioid Prescribing Practices
The Centers for Disease Control and Prevention (CDC) Guideline for Prescribing Opioids for Chronic Pain has reduced opioid-involved overdose cases.
CDC released an evidence-based guideline amidst escalating opioid-involved overdoses pandemic for doctors to treat their patients’ pain while balancing the risks and benefits of prescription opioid medications.

A new study focuses on opioid prescriptions that were filled by patients who had not used their insurance in the past year to fill any other opioid prescription before and after the 2016 guideline release.

The percentage of these “opioid-naïve” patients filling an opioid prescription dropped from nearly 12% in the first year to just over 9% in the final year – and the decline was already well under way before the guideline came out.

Those who did receive opioids had different trends in two ways: the number of days’ supply of opioids in their prescriptions, and the dose.

After the guideline’s release, initial opioid prescribing among these patients showed decreases in both the average days’ supply, and in doses larger than 50 MME (morphine milligram equivalents), compared with what would be expected from the pre-guideline trends.

The researchers make it clear that they cannot attribute any one change or trend to the CDC’s guideline. The analysis is published in JAMA Network Open.

Advertisement
The 2016 guideline was not intended to apply to patients with cancer, major surgical pain, and those in hospice or palliative care. Yet prescribing patterns for those populations have been shown in other studies to show that have changed since the guideline was issued.

“These findings, based on trends before and after the CDC guideline was released, show it may have catalyzed other changes, because it came from a trusted entity,” said Jason Goldstick, Ph.D., lead author of the analysis and a research associate professor at the U-M Medical School who is a member of the U-M Injury Prevention Center.

Advertisement
It is impossible to isolate the effect of the guideline itself, given all the activity around opioid prescribing, but it’s important to track these trends. They can used in future efforts that treat pain safely and effectively.



Source-Medindia


Advertisement

Home

Consult

e-Book

Articles

News

Calculators

Drugs

Directories

Education